LigaChem Biosciences
KOSDAQ:A141080
170.300,00
+ ₩4.100,00 (2,47%)
170.300,00
+₩4.100,00 (2,47%)
End-of-day quote: 04/07/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

₩46,01
Earnings Per Share
₩3,90k
Revenue Per Share
0,00%
Gross Margin %
₩6.050,53 B
Market Cap
₩9,15 B
Long-Term Debt
Earnings Per Share
₩46,01
Revenue Per Share
₩3,90k
Gross Margin %
0,00%
Market Cap
₩6.050,53 B
Long-Term Debt
₩9,15 B

Financials

Year Year 2025 2024 2023 2022 2021 2020 2019 2018 2016 2015
EPS Earnings Per Share ₩46,01 ₩224,00 ₩-2.595,00 ₩-1.845,00 ₩-970,00 ₩-307,00 ₩566,00 ₩-1.223,00 ₩780,50 ₩533,50
Earnings Earnings ₩1,67B ₩8,13B ₩-72,61B ₩-47,05B ₩-23,50B ₩-6,58B ₩12,14B ₩-25,90B ₩15,52B ₩9,65B
RPS Revenue Per Share ₩3,90k ₩3,47k ₩1,22k ₩1,31k ₩1,33k N/A ₩2,67k ₩1,19k ₩0,00 ₩608,07
Revenue Revenue ₩141,55B ₩125,90B ₩34,15B ₩33,41B ₩32,16B ₩49,39B ₩57,20B ₩25,24B ₩0,00M ₩11,00B
OCF Operating Cash Flow ₩-53,50B ₩78,48B ₩-62,24B ₩3,10B ₩-42,05B ₩-14,89B ₩25,22B ₩0,00M ₩0,00M ₩-8,78B
FCF Free Cash Flow ₩-81,44B ₩75,85B ₩-67,33B ₩-18,70B ₩-60,36B ₩-17,63B ₩21,85B ₩0,00M ₩0,00M ₩-9,15B
OM Operating Margin 0,00% -16,61% -236,70% -150,77% -86,16% 0,00% 14,64% -63,30% -60,96% 0,00%
GM % Gross Margin % 0,00% 87,33% 52,12% 53,42% 55,03% 0,00% 60,54% 23,41% 25,17% 61,37%
FCFS Free Cash Flow Per Share ₩0,00 ₩2,12k ₩-2.268,62 ₩-425,02 ₩-2.507,47 ₩0,00 ₩972,48 ₩-793,73 ₩-916,02 ₩-592,30
LT Debt Long-Term Debt N/A ₩9,15B N/A N/A ₩9,15B N/A ₩1,90B N/A ₩7,85B ₩9,83B
Sha. Stocks 36,28M 36,28M 27,98M 25,5M 24,23M 23,68M 21,44M 21,18M 19,88M 18,09M
×